keyword
https://read.qxmd.com/read/38621200/optimized-cytogenetic-risk-group-stratification-of-kmt2a-rearranged-pediatric-acute-myeloid-leukemia
#1
JOURNAL ARTICLE
Romy Elise van Weelderen, Christine J Harrison, Kim Klein, Yilin Jiang, Jonas Abrahamsson, Todd Alonzo, Richard Aplenc, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N Dworzak, Sarah Elitzur, José M Fernández Navarro, Alan S Gamis, Robert B Gerbing, Bianca F Goemans, Hester A de Groot-Kruseman, Erin M Guest, Shau Yin Ha, Henrik Hasle, Charikleia Kelaidi, Helene Lapillonne, Guy Leverger, Franco Locatelli, Takako Miyamura, Ulrika Noren-Nystrom, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, Michel C Zwaan, Gertjan J L Kaspers
Comprehensive international consensus on cytogenetic risk-group stratification of KMT2A-rearranged (KMT2A-r) pediatric acute myeloid leukemia (AML) is lacking. This retrospective (2005-2016) International Berlin-Frankfurt-Münster Study Group study on 1,256 children with KMT2A-r AML aimed to validate the prognostic value of established recurring KMT2A fusions and additional cytogenetic aberrations (ACAs), and secondly, to define additional, recurring KMT2A fusions and ACAs, evaluating their prognostic relevance...
April 15, 2024: Blood Advances
https://read.qxmd.com/read/38616479/characteristics-and-outcomes-of-patients-with-relapsed-refractory-multiple-myeloma-after-exposure-to-lenalidomide-in-first-line-of-therapy-a-single-center-database-review-in-greece
#2
JOURNAL ARTICLE
Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Foteini Theodorakakou, Magdalini Migkou, Maria Roussou, Panagiotis Malandrakis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Vassiliki Spiliopoulou, Maria Gavriatopoulou, Sachin Patel, Istvan Majer, Christos Boukis, Andriani Fetani, Meletios A Dimopoulos, Evangelos Terpos
BACKGROUND: The increasing use of lenalidomide (Len) in first-line (1L) therapy of multiple myeloma (MM) has led to a significant proportion of patients becoming Len-refractory following 1L treatment. However, there are limited real-world data on treatment strategies and outcomes of patients who become Len-refractory following 1L therapy. PATIENTS AND METHODS: This real-world retrospective cohort study analyzed Len-refractory and non-Len-refractory patients who received 1L Len and initiated second-line (2L) therapy at a Greek MM center...
March 19, 2024: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/38616211/what-is-new-in-acute-myeloid-leukemia-classification
#3
REVIEW
Hee Sue Park
Recently, the International Consensus Classification (ICC) and the 5th edition of the World Health Organization classification (WHO2022) introduced diagnostically similar yet distinct approaches, which has resulted in practical confusion. This review compares these classification systems for acute myeloid leukemia (AML), building up on the revised 4th edition of WHO (WHO2016). Both classifications retain recurrent genetic abnormalities as a primary consideration. However, they differ in terms of blast threshold...
April 15, 2024: Blood Research
https://read.qxmd.com/read/38615184/improved-long-term-survival-rate-in-the-responders-to-bortezomib-cyclophosphamide-dexamethasone-induction-therapy-in-a-transplant-eligible-cohort-of-predominantly-middle-age-multiple-myeloma-patients
#4
JOURNAL ARTICLE
Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Hazaa Al Zahrani, Ruah Al Yamany, Mostafa Saleh, Saud Alhayli, Zakia Al Somali, Ahmad Alotaibi, AlFadel AlShaibani, Farah Deeba, Maryam Asif, Syed Ahmed Osman Ali Ahmed, Feras Al Fraih, Marwan Shaheen, Ali Alahmari, Walid Rasheed, Naeem Arshad Chaudhri, Fahad Al Mohareb, Mahmoud Aljurf, Amr Hanbali
BACKGROUND: Multiple myeloma (MM) represents the second most common hematologic malignancy (15%). Induction with bortezomib, cyclophosphamide, and dexamthasone VCd (d: low dose dexamthasone) regimen is widely used due to its high effectiveness, low toxicity and good tolerability, particularly with renal impairment. Real-world data on the use of VCD in clinical practice is lacking. OBJECTIVES: Evaluate the real-world experience of the VCD regimen. DESIGN: Retrospective...
2024: Annals of Saudi Medicine
https://read.qxmd.com/read/38613208/therapeutic-benefit-of-oregano-oil-in-the-acute-idiosyncratic-hepatotoxicity-induced-by-carbon-tetrachloride-in-rats-adverse-effects-of-high-dose-of-oreganum
#5
JOURNAL ARTICLE
Damir Suljević, Muhamed Fočak, Rifat Škrijelj, Maja Mitrašinović-Brulić
Toxicity caused by carbon tetrachloride (CCl4 ) can lead to serious liver injury. The aim of the study is to investigate the protective effects of oregano oil (Origanum minutiflorum extract oil) against CCl4 -induced liver injury. Two doses of oregano oil were used in the experiment: a low dose (LD; 20 mg/kg) and a high dose (HD; 60 mg/kg) during 2 weeks. CCl4 caused severe liver damage, nucleolus destruction in hepatocytes and cytogenetic changes in the nucleus. Indirectly, CCl4 causes decreased protein synthesis and significantly high creatinine and urea values...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38612873/conventional-cytogenetic-analysis-and-array-cgh-snp-identify-essential-thrombocythemia-and-prefibrotic-primary-myelofibrosis-patients-who-are-at-risk-for-disease-progression
#6
JOURNAL ARTICLE
Joseph Tripodi, Ronald Hoffman, Douglas Tremblay, Daiva Ahire, John Mascarenhas, Marina Kremyanskaya, Vesna Najfeld
The Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-MPNs) are a heterogeneous group of clonal hematopoietic malignancies that include polycythemia vera (PV), essential thrombocythemia (ET), and the prefibrotic form of primary myelofibrosis (prePMF). In this study, we retrospectively reviewed the karyotypes from conventional cytogenetics (CC) and array Comparative Genomic Hybridization + Single Nucleotide Polymorphism (aCGH + SNP) in patients with ET or prePMF to determine whether the combined analysis of both methodologies can identify patients who may be at a higher risk of disease progression...
April 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611097/late-relapse-after-allogeneic-stem-cell-transplantation-in-patients-treated-for-acute-myeloid-leukemia-relapse-incidence-characteristics-role-of-conditioning-regimen-and-outcome
#7
JOURNAL ARTICLE
Chloé Antier, Maxime Jullien, Benoît Tessoulin, Marion Loirat, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Patrice Chevallier, Thierry Guillaume
Late relapse, beyond 2 years following alloHSCT for AML, is rare. Among the 376 patients allografted for AML in our center between 1990 and 2016, 142 (38%) relapsed. The majority (68%) of relapses occurred during the first year following transplantation. Beyond 2 years after alloHSCT, relapse was observed in 26 patients, representing 6.9% of the whole transplanted cohort and 18.3% of the relapsing patients. Cytogenetics at relapse was available in 21 patients and remained for 15 of them concordant to that at diagnosis...
April 5, 2024: Cancers
https://read.qxmd.com/read/38611011/real-world-outcome-and-prognostic-factors-in-mds-patients-treated-with-azacitidine-a-retrospective-analysis
#8
JOURNAL ARTICLE
Kamil Wiśniewski, Katarzyna Pruszczyk-Matusiak, Bartosz Puła, Ewa Lech-Marańda, Joanna Góra-Tybor
Azacitidine (AZA) is recognized as a vital drug used in the therapy of myelodysplastic syndromes (MDS) due to its beneficial effect on survival and quality of life. Nevertheless, many patients fail to respond to AZA treatment, as prognostic factors still are not identified. The present retrospective analysis included 79 patients with MDS treated with AZA as first-line therapy in a real-life setting. The percentage of patients with good, intermediate, and poor cytogenetics was 46.8%, 11.4%, and 34.2%, respectively...
March 29, 2024: Cancers
https://read.qxmd.com/read/38610955/donor-lymphocyte-infusion-in-the-treatment-of-post-transplant-relapse-of-acute-myeloid-leukemias-and-myelodysplastic-syndromes-significantly-improves-overall-survival-a-french-italian-experience-of-134-patients
#9
JOURNAL ARTICLE
Eugenia Accorsi Buttini, Cristina Doran, Michele Malagola, Vera Radici, Marco Galli, Vicky Rubini, Alessandro Leoni, Mirko Farina, Nicola Polverelli, Federica Re, Simona Bernardi, Mohamad Mohty, Domenico Russo, Eolia Brissot
BACKGROUND: Disease relapse after allogeneic stem cell transplantation (allo-SCT) is the main challenge for curing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We investigated the overall survival (OS) after allo-SCT relapse according to different therapeutic approaches. METHODS: We analyzed 134 patients who relapsed after allo-SCT performed between 2015 and 2021 at Saint-Antoine University Hospital, Paris and Spedali Civili di Brescia, Brescia...
March 26, 2024: Cancers
https://read.qxmd.com/read/38610607/flag-flag-ida-regimen-in-secondary-and-relapsed-refractory-acute-myeloid-leukemia-even-in-the-era-of-new-treatment-modalities-still-a-significant-player
#10
JOURNAL ARTICLE
Saša Anžej Doma, Matjaž Sever, Gorazd Jakoš, Helena Podgornik
(1) Background : Relapsed/refractory (r/r) and secondary acute myeloid leukemia are highlighted by chemoresistance and poor outcomes. The aim of the study was to assess the efficacy and toxicity of fludarabine, cytarabine, and granulocyte-colony stimulation factor (FLAG) with or without idarubicin (-Ida) and to discuss novel therapies in this setting. (2) Methods : Clinical and cytogenetic data on 130 consecutive patients with r/r and secondary AML treated at our center were retrospectively analyzed. (3) Results : There were 48, 56, and 26 patients with relapsed, refractory, and secondary AML, respectively...
March 22, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38608254/two-recurrent-types-of-igh-5-bcl2-breakpoints-representing-cytogenetic-ins-14-18-q32-q21q21-and-t-14-18-q32-q21-mediated-by-the-vdj-and-class-switch-recombination-processes-respectively
#11
JOURNAL ARTICLE
Fumiyo Maekawa, Masahiko Hayashida, Kayo Takeoka, Katsuhiro Fukutsuka, Miho Nakagawa, Takashi Akasaka, Shinichi Sakamoto, Shinji Sumiyoshi, Yoichiro Kobashi, Hitoshi Ohno
We describe two types of IGH :: BCL2 breakpoints involving the 5' region of BCL2 (5' BCL2 ). One was ins(14;18)(q32;q21q21) observed in 2 follicular lymphoma (FL) cases, in which IGH was cleaved at 3' of IGHD and 5' of IGHJ and BCL2 was cleaved at 5' BCL2 and downstream regions, and a 281- or 201-kilobase pair fragment containing the BCL2 protein-coding sequences was invertedly inserted into IGH . In another type observed in 2 FL and 2 chronic lymphocytic leukemia (CLL) cases, breakage and reunion occurred within the switch region associated with IGHM (Sµ) and 5' BCL2 , creating IGH Sµ::5' BCL2 fusion sequences on der(18)t(14;18)(q32;q21)...
April 12, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38607200/retrieval-of-trophoblast-cells-from-the-robertsonian-translocations-for-prenatal-diagnosis
#12
JOURNAL ARTICLE
Zhen Xu, Sheng Li, Long He
OBJECTIVE: To provide genetic information about the fetuses from carriers of Robertsonian (Rob) translocation and to explore the application value of extravillous trophoblasts (EVTs) cells collected from the cervical canal for prenatal diagnosis. METHOD: Trophoblast retrieval and isolation from the cervix (TRIC) is an approach that non-invasively isolates homogeneous trophoblast cells. In this study, the EVT cells were collected from the cervix of 20 pregnant women between 5-7 weeks gestation...
April 12, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38607189/correction-to-ceramide-contributes-to-pathogenesis-and-may-be-targeted-for-therapy-in-vcp-inclusion-body-myopathy
#13
(no author information available yet)
No abstract text is available yet for this article.
April 12, 2024: Human Molecular Genetics
https://read.qxmd.com/read/38603517/bone-marrow-findings-post-allogeneic-transplant-for-myeloproliferative-neoplasms-and-chronic-myelomonocytic-leukemia-with-increased-fibrosis
#14
JOURNAL ARTICLE
Srishti Gupta, Elizabeth L Courville
BACKGROUND: Allogeneic hematopoietic stem cell transplant for myeloid neoplasms with increased fibrosis is uncommon; morphologic features posttransplant can be concerning for persistent disease. METHODS: In this retrospective study, we identified 22 patients transplanted for myeloproliferative neoplasms or chronic myelomonocytic leukemia with fibrosis at our institution, and reviewed slides from pretransplant and posttransplant bone marrow biopsies. Clinical features and results of molecular, chimerism, and cytogenetic studies were retrieved from the medical record...
April 11, 2024: Laboratory Medicine
https://read.qxmd.com/read/38601956/%C3%AF-the-role-of-cellular-polyploidy-in-the-regeneration-of-the-cirrhotic-liver-in-rats-and-humans
#15
JOURNAL ARTICLE
Natalia N Bezborodkina, Vsevolod Ya Brodsky, Boris N Kudryavtsev
Polyploidy is a condition in which a cell has multiple diploid sets of chromosomes. Two forms of polyploidy are known. One of them, generative polyploidy, is characteristic of all cells of the organism, while the other form develops only in some somatic tissues at certain stages of postnatal ontogenesis. Whole genome duplication has played a particularly important role in the evolution of plants and animals, while the role of cellular (somatic) polyploidy in organisms remains largely unclear. In this work we investigated the contribution of cellular polyploidy to the normal and the reparative liver growth of Rattusnorvegicus (Berkenhout, 1769) and Homosapiens Linnaeus, 1758...
2024: Comparative Cytogenetics
https://read.qxmd.com/read/38601032/molecular-and-cytogenetic-analyses-in-geranium-macrorrhizum-l-wild-italian-plants
#16
JOURNAL ARTICLE
Irene Cardinali, Marilena Ceccarelli
Geranium macrorrhizum L. is a herbaceous species native to southern Europe and was introduced in central Europe and North America. It is also widely distributed in Italy. In this study, molecular and cytogenetic analyses were carried out on 22 wild plants, collected in central and southern Italy, compared with five cultivated plants, with the main purpose to identify those living near the Marmore waterfalls in central Italy, recently described as the new species Geranium lucarinii . Four barcoding markers ( rbcL , matK , trnH-psbA intergenic spacer and internal transcribed spacer region) were sequenced and their variability among the plants was evaluated...
April 2024: Royal Society Open Science
https://read.qxmd.com/read/38599340/circulating-plasma-cells-as-a-predictive-biomarker-in-multiple-myeloma-an-updated-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Yu Hu, Chunyan Sun
BACKGROUND: Circulating plasma cells (CPCs) are defined by the presence of peripheral blood clonal plasma cells, which would contribute to the progression and dissemination of multiple myeloma (MM). An increasing number of studies have demonstrated the predictive potential of CPCs in the past few years. Therefore, there is a growing need for an updated meta-analysis to identify the specific relationship between CPCs and the prognosis of MM based on the current research status. METHODS: The PubMed, Embase, and Cochrane Library databases were screened to determine eligible studies from inception to November 5, 2023...
December 2024: Annals of Medicine
https://read.qxmd.com/read/38597979/predicting-cytogenetic-risk-in-multiple-myeloma-using-conventional-whole-body-mri-spinal-dynamic-contrast-enhanced-mri-and-spinal-diffusion-weighted-imaging
#18
JOURNAL ARTICLE
Thomas Van Den Berghe, Bert Verberckmoes, Nicolas Kint, Steven Wallaert, Nicolas De Vos, Chloé Algoet, Maxim Behaeghe, Julie Dutoit, Nadine Van Roy, Philip Vlummens, Amélie Dendooven, Jo Van Dorpe, Fritz Offner, Koenraad Verstraete
OBJECTIVES: Cytogenetic abnormalities are predictors of poor prognosis in multiple myeloma (MM). This paper aims to build and validate a multiparametric conventional and functional whole-body MRI-based prediction model for cytogenetic risk classification in newly diagnosed MM. METHODS: Patients with newly diagnosed MM who underwent multiparametric conventional whole-body MRI, spinal dynamic contrast-enhanced (DCE-)MRI, spinal diffusion-weighted MRI (DWI) and had genetic analysis were retrospectively included (2011-2020/Ghent University Hospital/Belgium)...
April 10, 2024: Insights Into Imaging
https://read.qxmd.com/read/38597487/karyotypic-changes-and-diversification-time-in-epinephelidae-groupers-perciformes-implications-on-reproductive-isolation
#19
JOURNAL ARTICLE
Karlla Danielle J Amorim, Gideão W W F Costa, Clóvis C Motta-Neto, Rodrigo X Soares, Amanda T Borges, Daniel D Benetti, Marcelo B Cioffi, Luiz A C Bertollo, Alongklod Tanomtong, Wagner F Molina
Groupers (Epinephelidae and Serranidae) have attracted special attention to fish farming, and their species offer good opportunities for successful hybridizations. Cytogenetic data allow a better understanding of the role of karyotypic diversification in the acquisition of post-zygotic reproductive isolation (RI). Thus, chromosomal analyses were performed on E. striatus (Caribbean Sea), E. coioides and E. tauvina (Indo-Pacific Region), using standard procedures and mapping of six repetitive DNA classes by the in situ hybridization...
2024: Anais da Academia Brasileira de Ciências
https://read.qxmd.com/read/38596106/disease-controlled-multiple-myeloma-in-a-patient-with-17p-gain-and-t-4-14-a-case-report
#20
Xinyu Tang, Ruirong Xu, Wei Zheng, Yanfeng Zhou, Siyuan Cui, Yan Wang
Cytogenetic karyotypes such as t(4; 14), del(17p), t(14; 16), t(14; 20), and TP53 mutations are associated with high-risk multiple-myeloma (MM) and indicate poor prognosis. Therefore, cytogenetic testing is extremely important for determining prognosis of MM. However, the aberrant karyotypes reported in the current literature are incomplete. The cytogenetic karyotype 17p gain has not received widespread attention, and its relationship with MM prognosis is unknown; additionally, the prognosis of 17p gain associated with t(4; 14) has not been studied in depth...
April 15, 2024: Heliyon
keyword
keyword
2029
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.